DB
GILD icon

Dmitry Balyasny’s Gilead Sciences GILD Stock Holding History

Dmitry Balyasny’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.92M Buy
70,600
+8,100
+13% +$1.07M 0.01% 1101
2026
Q1 		$8.71M Buy
62,500
+11,900
+24% +$1.67M 0.01% 1099
2025
Q4 		$6.21M Sell
50,600
-2,100
-4% -$255K 0.01% 1284
2025
Q3 		$5.85M Buy
52,700
+1,200
+2% +$136K 0.01% 1298
2025
Q2 		$5.71M Sell
51,500
-300
-0.6% -$31.9K 0.01% 1222
2025
Q1 		$5.8M Buy
51,800
+11,800
+30% +$1.22M 0.01% 1176
2024
Q4 		$3.69M Buy
40,000
+14,500
+57% +$1.31M 0.01% 1413
2024
Q3 		$2.14M Buy
25,500
+22,000
+629% +$1.68M ﹤0.01% 1640
2024
Q2 		$240K Sell
3,500
-70,100
-95% -$4.68M ﹤0.01% 2288
2024
Q1 		$5.39M Sell
73,600
-5,200
-7% -$400K 0.01% 1189
2023
Q4 		$6.38M Sell
78,800
-42,200
-35% -$3.28M 0.01% 1037
2023
Q3 		$9.07M Hold
121,000
– – 0.02% 879
2023
Q2 		$9.33M Hold
121,000
– – 0.02% 818
2023
Q1 		$10M Hold
121,000
– – 0.03% 775
2022
Q4 		$10.4M Sell
121,000
-39,200
-24% -$3.1M 0.03% 736
2022
Q3 		$9.88M Buy
160,200
+108,300
+209% +$6.83M 0.03% 688
2022
Q2 		$3.21M Buy
+51,900
New +$3.21M 0.01% 1140
2021
Q3 		– Sell
-11,400
Closed -$785K – 2110
2021
Q2 		$785K Buy
+11,400
New +$761K ﹤0.01% 1392
2020
Q4 		– Sell
-119,900
Closed -$7.58M – 1466
2020
Q3 		$7.58M Buy
+119,900
New +$8.31M 0.06% 470
2017
Q3 		– Sell
-365,000
Closed -$25.8M – 1955
2017
Q2 		$25.8M Buy
+365,000
New +$24.3M 0.11% 263
2016
Q2 		– Sell
-300,000
Closed -$27.6M – 1266
2016
Q1 		$27.6M Buy
+300,000
New +$27.1M 0.16% 193
2015
Q2 		– Sell
-200,000
Closed -$19.6M – 1211
2015
Q1 		$19.6M Buy
200,000
+100,000
+100% +$10.2M 0.16% 203
2014
Q4 		$9.43M Buy
+100,000
New +$10.3M 0.09% 310

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dmitry Balyasny's GILD Position: Q2 2026 in Review

Dmitry Balyasny increased its Gilead Sciences (GILD) stake by 2,869% in Q2 2026, buying an estimated $74.7M and bringing the position to 587,082 shares worth $74.2M. The position accounts for 0.09% of the portfolio, ranked #255.

Dmitry Balyasny first reported a position in GILD in Q1 2015 and has held it in 36 quarters since. The position peaked at $101M in Q1 2015. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dmitry Balyasny held 587,082 shares of Gilead Sciences worth $74.2M as of Q2 2026.
  • Dmitry Balyasny bought 567,308 Gilead Sciences shares in Q2 2026, an estimated $74.7M.
  • Gilead Sciences made up 0.09% of Dmitry Balyasny's portfolio in Q2 2026, its #255 holding.
  • Dmitry Balyasny first reported a position in Gilead Sciences in Q1 2015 and has held it in 36 quarters since.
  • Dmitry Balyasny's Gilead Sciences position peaked at $101M in Q1 2015.
  • 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.